Navigation Links
OBN's 2012 Annual Awards Dinner Celebrates UK Bioscience Success Stories
Date:9/12/2012

r and better absorbed by the body compared with conventional tablets.  

FoetoH, Best Emerging Medtech

Award Presented by Team Consulting

FoetoH is a new portable technology for the care of babies before they are born. FoetoH targets foetal health and helps prevent stillbirths by providing a better quality and frequency of foetal monitoring anytime, anywhere and by anyone.

PsiOxus Therapeutics, Best Biotech Fundraiser

Award Presented by Pivotal Scientific

In July 2012, PsiOxus Therapeutics announced its closing of a Series B round of equity financing totalling £22 million, including investments from investors Imperial Innovations Invesco Perpetual, SR One and Lundbeckfond Ventures. The financing round will enable PsiOxus to advance the clinical development of ColoAd1, a systemically available oncolytic vaccine for the treatment of colorectal cancer.

Oxford Nanopore Technologies, Best Medtech Fundraiser

Award Presented by Milton Park

Oxford Nanopore is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable technology platform and miniaturised instrument are designed to offer substantial benefits in a variety of applications including DNA and protein sequencing. In May 2012, Oxford Nanopore announced a further fundraising of £31.4 million making them the largest disclosed fundraiser in the cluster this year.

EUSA Pharma,  Best Biotech Dealmaker

Award Presented by Manches

In June 2012, EUSA Pharma was acquired by Jazz Pharmaceuticals for $680 million. The acquisition brings a portfolio of seven products including a significant new specialty product to the Jazz Pharmaceuticals U.S. portfolio including Erwinaze™ (asparaginase Erwiniachrysanthemi), a life-saving treatment for patients with acute ly
'/>"/>

SOURCE OBN
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
2. Heart Failure Society of America Annual Meeting To Feature Several Satellite Symposia
3. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
4. Grifols Awards Winners of the 9th Annual eALTA Research Fellowship at 2012 ERS Meeting
5. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
6. Discuss Early Results of the DIAN Trial at CBIs 6th Annual Alzheimers Drug Development Summit
7. CBIs 9th Annual Forum on Formulary and Reimbursement Strategies: Payer Perspectives
8. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
9. Organogenesis Announces Annual College Scholarship Award Winner
10. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
11. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... Mass., Feb. 26, 2015   Synageva BioPharma ... biopharmaceutical company developing therapeutic products for rare disorders, ... provided 2015 goals, other key objectives, and financial ... call today at 4:30 p.m. EST to review ... update.  To participate in today,s call by telephone, ...
(Date:2/26/2015)... The Movement for Indefinite Life Extension ... extension technologies and awareness. The event is taking place ... March 21st 2015, in a live Google Hangout broadcast ... Founder of MILE, says, “Our lives are in our ... for Indefinite Life Extension is raising awareness about bio-sciences ...
(Date:2/26/2015)... Feb. 26, 2015 BioEnterprise today announced that ... attracted more than $2 billion in growth funding during ... national investors, strategic sources, state – including the Ohio ... the $2 billion has been raised in the past ... the heels of the BioEnterprise Midwest Healthcare Growth ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4
... from $31.0 million in Q1,08 , - Home Market: $14.4 ... Gross Margin: 21%, up from 13% in Q1,08 , - ... 8 NxStage Medical, Inc. (Nasdaq: NXTM ), ... revenue for the first quarter of 2009 of $33.7 million, ...
... DIEGO, May 7 Cadence Pharmaceuticals, Inc. (Nasdaq: ... on in-licensing, developing and commercializing proprietary product candidates ... reported financial results for the first quarter ended ... development program for Acetavance(TM), our proprietary formulation of ...
... May 7 Encorium Group, Inc. ... contract research organization (CRO) that provides design, development, ... registries to many of the world,s leading pharmaceutical ... Ph.D. has been appointed Head Consultant of Encorium,s ...
Cached Biology Technology:NxStage Reports First Quarter 2009 Financial Results 2NxStage Reports First Quarter 2009 Financial Results 3NxStage Reports First Quarter 2009 Financial Results 4NxStage Reports First Quarter 2009 Financial Results 5NxStage Reports First Quarter 2009 Financial Results 6NxStage Reports First Quarter 2009 Financial Results 7NxStage Reports First Quarter 2009 Financial Results 8NxStage Reports First Quarter 2009 Financial Results 9NxStage Reports First Quarter 2009 Financial Results 10NxStage Reports First Quarter 2009 Financial Results 11Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 2Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 3Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 4Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 5Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 6Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 7Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 2Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 3Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team 4
(Date:1/22/2015)... and POINT ROBERTS, Washington , ... source covering leading sectors including technology and tech stocks, releases ... marketplace featuring master pickpocket and security consultant Apollo Robbins ... stolen and talks about the Wocket™ biometric smart wallet, a ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  Since its launch in December ... people to eliminate the pain of trying to remember their ... own biometrics fused to their smartphones. To assist people who ... , the company that created 1U and focuses on redefining ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
... New research offers tantalizing clues as to why some ... kill themselves. The research is published in the ... Psychological Association (APA). , Neuroscientists at the University of ... doses of fluoxetine hydrochloride, which is sold in the ...
... remarkable fossils found in New Zealand will prompt a major rewrite ... "land of birds" was once home to mammals as well. , ... leg - belonged to a unique, mouse-sized land animal unlike any ... fossil bed, in the Central Otago region of South Island. ...
... during cell division, first described in the late 1800s ... in biology classes, has long fascinated biologists. However, ... division, the "chromosome-spindle" connection, which is critical for the ... elusive. , Researchers at the University of ...
Cached Biology News:Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2Tiny bones rewrite textbooks 2Two central mysteries in genome inheritance solved at UCSD 2Two central mysteries in genome inheritance solved at UCSD 3